Evidence map›Paper›PMID 33938968›Full record

ArticleDiabetologia2021

Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes.

Hironobu Sasaki, Yoshifumi Saisho, Jun Inaishi, Yuusuke Watanabe, Tami Tsuchiya, Masayoshi Makio, Midori Sato, Masaru Nishikawa, Minoru Kitago, Taketo Yamada and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Evolving Characteristics of Type 2 Diabetes Mellitus in East Asia.Endocrinology and metabolism (Seoul, Korea) · 2025
    Review
  5. Article
  6. Article
  7. The spontaneous-diabetes rat: a model of noninsulin dependent diabetes mellitus by Yoshio Goto and Masaei Kakizaki (1981).Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2024
    Review
  8. Pancreatic δ Cells: An Overlooked Cell in Focus.Advances in anatomy, embryology, and cell biology · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Islet Inflammation and β Cell Dysfunction in Type 2 Diabetes.Handbook of experimental pharmacology · 2022
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Hironobu SasakiDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Yoshifumi SaishoDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. ysaisho@keio.jp.ORCID 0000-0002-6071-4393
Jun InaishiDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Yuusuke WatanabeDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Tami TsuchiyaDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Masayoshi MakioDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Midori SatoDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Masaru NishikawaDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Minoru KitagoDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Taketo YamadaDepartment of Pathology, Keio University School of Medicine, Tokyo, Japan.
Hiroshi ItohDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Keio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisType 2 diabetes is characterised by reduced beta cell mass (BCM). However, it remains uncertain whether the reduction in BCM in type 2 diabetes is due to a decrease in size or number of beta cells. Our aim was to examine the impact of beta cell size and number on islet morphology in humans with and without type 2 diabetes.

methodsPancreas samples were obtained from 64 Japanese adults with (n = 26) and without (n = 38) type 2 diabetes who underwent pancreatectomy. Using pancreatic tissues stained for insulin, we estimated beta cell size based on beta cell diameter. Beta cell number was estimated from the product of fractional beta cell area and pancreas volume divided by beta cell size. The associations of beta cell size and number with islet morphology and metabolic status were examined.

resultsBoth beta cell size (548.7 ± 58.5 vs 606.7 ± 65.0 μm CONCLUSIONS/

interpretationBoth beta cell size and number were reduced in participants with type 2 diabetes, with the relative reduction in beta cell number being greater. Decrease in beta cell number appears to be a major contributor to reduced BCM in type 2 diabetes.

Indexed as

Cell CountCell SizeAgedChromatography, High Pressure LiquidDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansInsulin-Secreting CellsMaleMiddle AgedPancreatectomyGlycated Hemoglobinhemoglobin A1c protein, humanBeta cell massBeta cell numberBeta cell sizeHuman pancreasJapanese

Identifiers

PMID33938968
PMCPMC8245378
OpenAlexW3157128465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.